The global OsteoporosisDrugs Market size is expected to value at USD 16.3 billion by 2025. The osteoporosis drug industry is subject to witness a substantial growth due to the rise in elderly population and increase in the occurrence of target diseases like osteoporosis. Global occurrence of osteoporosis along with high demand for drugs in prophylaxis and treatment is propelling the growth of osteoporosis drug market, in the recent years. Globally, the osteoporosis drugs industry is predicted to grow at higher CAGR over next seven years, providing numerous opportunities for market players to invest for research and development in the osteoporosis drugs.
Osteoporosis
is a primary cause of reduced bone density inducing the pain with a minor form
of injury or trauma. As many as nine million people have been reported
suffering from the osteoporosis disease on annual basis across the globe. Such
factors are causing frequent osteoporotic conditions every three seconds. Prime
victims of the disease are menopausal women. For instance, one out of three
women above the age of fifty experiences an osteoporotic fracture. These
factors are responsible for the growth of osteoporosis drugs market, thus
creating lucrative opportunities for market players, in recent years.
Substantial rise in the elderly population in both developed and developing
economies across the globe are driving the demand for osteoporosis drugs.
The
osteoporosis drug industry is broadly categorized into five major segments
based on the product type such as bisphosphonates, parathyroid hormone therapy,
calcitonin, Selective Estrogen Inhibitors Modulator (SERM), and rank ligand
inhibitors. The rank ligand inhibitors is considered as one of the faster
growing segment in the osteoporosis drug market with substantial revenue
generation in the last few years. Increase in preference by healthcare
professional due to positive outcomes in patient attributes to the growing
popularity of the rank ligand inhibitors segment. The Selective Estrogen
Inhibitors Modulator (SERM) segment also witnesses substantial growth owing to
the increasing adoption in conjunction with other drugs to impart a synergistic
effect.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/osteoporosis-drug-market/request-sample
The
osteoporosis drugs industry is divided by region such as North America, Europe,
Asia-Pacific, Latin America and Africa. North America has shown major growth in
recent years owing to the rise in adoption of latest technologies in medicine
& pharmaceutical sector, increase in number of incidences related to
osteoporosis disorders, and existence of well-established healthcare
infrastructure. Asia-Pacific region is predicted to hold major market share in
the osteoporosis drugs market with massive growth in forecast period. Countries
such as India, China and Japan are leading the Asia-Pacific market with growing
elderly population, rising healthcare expenditure, improved clinical
facilities, and significant investment by leading industry players considering
potential opportunities in the region.
The
key players in the osteoporosis drug industry are Actavis Inc., DePuy Synthes
Companies, Zimmer Biomet Holdings, Inc., Stryker Co., Integra LifeSciences Co.,
Pfizer Inc., and Dr. Reddy’s Laboratory.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/osteoporosis-drug-market
Global Osteoporosis Product Outlook
(Revenue, USD Million, 2014 - 2025)
• Branded
• Bisphosphonates
• Parathyroid Hormone Therapy
• Calcitonin
• Selective Estrogen Inhibitors
Modulator(SERM)
• Rank Ligand Inhibitors
• Others
• Generics
Osteoporosis Drugs Regional Outlook
(Revenue, USD Billion, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
Read more insights on @
https://latestmarkettrends.news.blog
Get in touch
At Million Insights, we work with the aim to reach the highest levels
of customer satisfaction. Our representatives strive to understand diverse
client requirements and cater to the same with the most innovative and
functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Comments
Post a Comment